SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 3 filers reported holding SEATTLE GENETICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,581,379 | +51.6% | 21,595 | +37.6% | 0.04% | +80.0% |
| Q2 2023 | $3,021,430 | +964.8% | 15,699 | +611.0% | 0.02% | +1150.0% |
| Q4 2022 | $283,750 | -84.4% | 2,208 | -78.5% | 0.00% | -88.2% |
| Q2 2022 | $1,815,000 | +136.9% | 10,257 | +93.0% | 0.02% | +183.3% |
| Q1 2022 | $766,000 | +23.7% | 5,315 | +32.8% | 0.01% | +100.0% |
| Q4 2021 | $619,000 | -49.2% | 4,001 | -44.2% | 0.00% | -62.5% |
| Q3 2021 | $1,218,000 | -74.3% | 7,171 | -76.1% | 0.01% | -75.8% |
| Q2 2021 | $4,731,000 | +391.3% | 29,966 | +332.3% | 0.03% | +450.0% |
| Q1 2021 | $963,000 | -65.9% | 6,932 | -57.0% | 0.01% | -57.1% |
| Q4 2020 | $2,823,000 | +49.0% | 16,119 | +66.6% | 0.01% | -22.2% |
| Q3 2020 | $1,894,000 | -0.4% | 9,678 | -13.6% | 0.02% | -10.0% |
| Q2 2020 | $1,902,000 | +16.4% | 11,196 | -21.0% | 0.02% | -4.8% |
| Q1 2020 | $1,634,000 | +7.2% | 14,165 | +6.2% | 0.02% | +110.0% |
| Q4 2019 | $1,524,000 | – | 13,337 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
| Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
| NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
| Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
| Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
| Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
| Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
| Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
| EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
| Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |